Research Alliance Corp. I (RACA) relating to its proposed merger with POINT Biopharma, Inc. Under the terms of the agreement, RACA will acquire POINT through a reverse merger, with POINT emerging as a publicly traded company.
Research Alliance Corp. I (RACA) relating to its proposed merger with POINT Biopharma, Inc. Under the terms of the agreement, RACA will acquire POINT through a reverse merger, with POINT emerging as a publicly traded company.